NO175782C - Fremgangsmåte til fremstilling og rensing av amfifile proteiner i aggregatform produsert i celler og deres anvendelse - Google Patents

Fremgangsmåte til fremstilling og rensing av amfifile proteiner i aggregatform produsert i celler og deres anvendelse

Info

Publication number
NO175782C
NO175782C NO885738A NO885738A NO175782C NO 175782 C NO175782 C NO 175782C NO 885738 A NO885738 A NO 885738A NO 885738 A NO885738 A NO 885738A NO 175782 C NO175782 C NO 175782C
Authority
NO
Norway
Prior art keywords
cells
purification
preparation
form produced
aggregate form
Prior art date
Application number
NO885738A
Other languages
English (en)
Norwegian (no)
Other versions
NO885738L (no
NO885738D0 (no
NO175782B (no
Inventor
Johann Eibl
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO885738D0 publication Critical patent/NO885738D0/no
Publication of NO885738L publication Critical patent/NO885738L/no
Publication of NO175782B publication Critical patent/NO175782B/no
Publication of NO175782C publication Critical patent/NO175782C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
NO885738A 1987-12-23 1988-12-23 Fremgangsmåte til fremstilling og rensing av amfifile proteiner i aggregatform produsert i celler og deres anvendelse NO175782C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87119172A EP0321606B1 (de) 1987-12-23 1987-12-23 Zelluläre amphipatische Proteine in aggregierten Formen und Verfahren zur Herstellung und Reinigung diese Proteine

Publications (4)

Publication Number Publication Date
NO885738D0 NO885738D0 (no) 1988-12-23
NO885738L NO885738L (no) 1989-06-26
NO175782B NO175782B (no) 1994-08-29
NO175782C true NO175782C (no) 1994-12-07

Family

ID=8197541

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885738A NO175782C (no) 1987-12-23 1988-12-23 Fremgangsmåte til fremstilling og rensing av amfifile proteiner i aggregatform produsert i celler og deres anvendelse

Country Status (8)

Country Link
EP (1) EP0321606B1 (ja)
JP (1) JP2656098B2 (ja)
AT (1) ATE95188T1 (ja)
DE (1) DE3787654D1 (ja)
DK (1) DK628188A (ja)
ES (1) ES2059355T3 (ja)
FI (2) FI96864C (ja)
NO (1) NO175782C (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
US5914390A (en) * 1997-05-12 1999-06-22 Celtrix Pharmaceuticals, Inc. Methods for increasing yields of recombinant proteins
DE19939246A1 (de) * 1999-08-19 2001-02-22 Phasys Gmbh M Rückfaltung von Membranproteinen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61233700A (ja) * 1984-12-24 1986-10-17 ジエネンテク，インコ−ポレイテツド 分子クロ−ンされたエイズ関連ポリペプチド
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
JPS62198627A (ja) * 1986-02-26 1987-09-02 Biseibutsu Kagaku Kenkyusho:Kk オ−エスキ−病可溶化抗原ワクチン

Also Published As

Publication number Publication date
FI96864B (fi) 1996-05-31
ATE95188T1 (de) 1993-10-15
FI97058B (fi) 1996-06-28
EP0321606B1 (de) 1993-09-29
ES2059355T3 (es) 1994-11-16
DK628188D0 (da) 1988-11-10
NO885738L (no) 1989-06-26
FI97058C (fi) 1996-10-10
JP2656098B2 (ja) 1997-09-24
FI953141A0 (fi) 1995-06-22
DE3787654D1 (de) 1993-11-04
JPH02798A (ja) 1990-01-05
NO885738D0 (no) 1988-12-23
FI885629A0 (fi) 1988-12-02
FI96864C (fi) 1996-09-10
EP0321606A1 (de) 1989-06-28
FI885629A (fi) 1989-06-24
FI953141A (fi) 1995-06-22
NO175782B (no) 1994-08-29
DK628188A (da) 1989-06-24

Similar Documents

Publication Publication Date Title
DE3774751D1 (de) System zum herstellen von kontinuierlichen langen keramischen gegenstaenden.
DE3583930D1 (de) Reinigung von loesungen des bayer-verfahrens.
DE3768402D1 (de) Polyalkylenglykoliminodiessigsaeure enthaltende verstaerkte reinigungsmittel.
NO871435L (no) Fremgangsmaate for fremstilling av blokkstoepte vaskemidler.
ATE47725T1 (de) Zum hervorrufen von aids geeigneter retrovirus vom typ hiv-2, sowie seine antigen- und nukleinsaeure-bestandteile.
NO892217D0 (no) Manoevreringsanordning for lasteskuffe.
NO874108L (no) Fremgangsmaate for raffinering av silisium og silisium renset ved fremgangsmaaten.
IT1216852B (it) Procedimento ed impianto per la depurazione di acque residue, in particolare di acque residue urbane.
DK333083D0 (da) 2-aza-bicyclo(2.2.2)octan-3-carboxylsyrederivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter og disses fremstilling
ATE114713T1 (de) Biomasse zur produktion von virus/virusantigen.
DE3887591D1 (de) Pinacidil zur Behandlung von pulmonaler Hypertonie oder Rechtsversagen.
NO175782C (no) Fremgangsmåte til fremstilling og rensing av amfifile proteiner i aggregatform produsert i celler og deres anvendelse
DE3485321D1 (de) 2,5-diketo-d-glukonsaeure-reduktase.
DE68919656D1 (de) Enzymhaltige Detergenszusammensetzungen und ihre Verwendung.
ATE152168T1 (de) Xylanase, bazillusstämme die xylanase produzieren und ihre verwendung
NO882255L (no) Fremgangsmaate for fremstilling av olefin-maleinsyreanhydrid-kopolymer i form av partikler.
DE3485210D1 (de) Immobilisierte enzymzusammensetzungen.
NO871017D0 (no) Opphengningsplate.
ATE114720T1 (de) Somatische embryogenese von kürbissen.
DE3784300D1 (de) Geformtes kalziumsilikatprodukt.
DE3673387D1 (de) Kuppelstueck zum verbinden von containern.
IT1178489B (it) Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante
IT8719184A0 (it) Gastroduodenale. composizioni farmaceutiche ad azione sinergica antisecretoria per la cicatrizzazione dell'ulcera
DK0592574T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner og værtsceller anvendt derved
DE3872769D1 (de) Gittertraeger.